This preferred scenario recognizes that the new generation of molecularly targeted medicines has the prospective for personalized medicine as well as the possibility of additional efficacious and less toxic antitumor therapies in individuals who have defined molecular aberrations. Essential molecular targets or pathways which are crucial to selected cancers, or that present possibilities for synthetic lethality,
Showing posts with label AG 879. Show all posts
Showing posts with label AG 879. Show all posts